vs
Side-by-side financial comparison of CAMDEN NATIONAL CORP (CAC) and Cytek Biosciences, Inc. (CTKB). Click either name above to swap in a different company.
CAMDEN NATIONAL CORP is the larger business by last-quarter revenue ($64.3M vs $62.1M, roughly 1.0× Cytek Biosciences, Inc.). CAMDEN NATIONAL CORP runs the higher net margin — 34.0% vs -70.9%, a 104.9% gap on every dollar of revenue. Over the past eight quarters, CAMDEN NATIONAL CORP's revenue compounded faster (22.6% CAGR vs 17.7%).
Camden National Bank is a commercial bank headquartered in Camden, Maine, operating as the principal subsidiary of Camden National Corporation, a publicly traded bank holding company. Founded in 1875, the bank became a direct, wholly owned subsidiary of the holding company following a corporate reorganization in 1984. Following the 2025 merger with Northway Financial, the combined institution has approximately $7.0 billion in assets.
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
CAC vs CTKB — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $64.3M | $62.1M |
| Net Profit | $21.9M | $-44.1M |
| Gross Margin | — | 52.9% |
| Operating Margin | — | -9.0% |
| Net Margin | 34.0% | -70.9% |
| Revenue YoY | — | 8.1% |
| Net Profit YoY | — | -557.1% |
| EPS (diluted) | $1.29 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $64.3M | — | ||
| Q4 25 | $68.1M | $62.1M | ||
| Q3 25 | $65.4M | $52.3M | ||
| Q2 25 | $62.3M | $45.6M | ||
| Q1 25 | $60.1M | $41.5M | ||
| Q4 24 | $47.6M | $57.5M | ||
| Q3 24 | $45.0M | $51.5M | ||
| Q2 24 | $42.8M | $46.6M |
| Q1 26 | $21.9M | — | ||
| Q4 25 | $22.6M | $-44.1M | ||
| Q3 25 | $21.2M | $-5.5M | ||
| Q2 25 | $14.1M | $-5.6M | ||
| Q1 25 | $7.3M | $-11.4M | ||
| Q4 24 | $14.7M | $9.6M | ||
| Q3 24 | $13.1M | $941.0K | ||
| Q2 24 | $12.0M | $-10.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | 52.9% | ||
| Q3 25 | — | 52.7% | ||
| Q2 25 | — | 52.3% | ||
| Q1 25 | — | 48.6% | ||
| Q4 24 | — | 58.5% | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 54.6% |
| Q1 26 | — | — | ||
| Q4 25 | 41.5% | -9.0% | ||
| Q3 25 | 40.5% | -17.6% | ||
| Q2 25 | 28.5% | -23.3% | ||
| Q1 25 | 10.3% | -36.1% | ||
| Q4 24 | 38.7% | 5.2% | ||
| Q3 24 | 35.2% | -8.2% | ||
| Q2 24 | 34.7% | -18.3% |
| Q1 26 | 34.0% | — | ||
| Q4 25 | 33.1% | -70.9% | ||
| Q3 25 | 32.4% | -10.5% | ||
| Q2 25 | 22.6% | -12.2% | ||
| Q1 25 | 12.2% | -27.5% | ||
| Q4 24 | 30.8% | 16.8% | ||
| Q3 24 | 29.1% | 1.8% | ||
| Q2 24 | 28.0% | -22.4% |
| Q1 26 | $1.29 | — | ||
| Q4 25 | $1.33 | — | ||
| Q3 25 | $1.25 | — | ||
| Q2 25 | $0.83 | — | ||
| Q1 25 | $0.43 | — | ||
| Q4 24 | $1.00 | — | ||
| Q3 24 | $0.90 | — | ||
| Q2 24 | $0.81 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $90.9M |
| Total DebtLower is stronger | $514.4M | — |
| Stockholders' EquityBook value | $710.0M | $341.7M |
| Total Assets | $7.0B | $461.5M |
| Debt / EquityLower = less leverage | 0.72× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $90.9M | ||
| Q3 25 | — | $93.3M | ||
| Q2 25 | — | $75.5M | ||
| Q1 25 | — | $95.3M | ||
| Q4 24 | — | $98.7M | ||
| Q3 24 | — | $162.3M | ||
| Q2 24 | — | $177.9M |
| Q1 26 | $514.4M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $710.0M | — | ||
| Q4 25 | $696.6M | $341.7M | ||
| Q3 25 | $676.4M | $378.6M | ||
| Q2 25 | $652.1M | $377.6M | ||
| Q1 25 | $640.1M | $379.6M | ||
| Q4 24 | $531.2M | $395.7M | ||
| Q3 24 | $529.9M | $385.5M | ||
| Q2 24 | $508.3M | $389.1M |
| Q1 26 | $7.0B | — | ||
| Q4 25 | $7.0B | $461.5M | ||
| Q3 25 | $7.0B | $494.9M | ||
| Q2 25 | $6.9B | $493.3M | ||
| Q1 25 | $7.0B | $482.6M | ||
| Q4 24 | $5.8B | $499.5M | ||
| Q3 24 | $5.7B | $491.2M | ||
| Q2 24 | $5.7B | $483.7M |
| Q1 26 | 0.72× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-771.0K |
| Free Cash FlowOCF − Capex | — | $-1.8M |
| FCF MarginFCF / Revenue | — | -2.9% |
| Capex IntensityCapex / Revenue | — | 1.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-8.8M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $63.9M | $-771.0K | ||
| Q3 25 | $36.1M | $-3.9M | ||
| Q2 25 | $6.0M | $108.0K | ||
| Q1 25 | $1.0M | $-125.0K | ||
| Q4 24 | $60.9M | $2.0M | ||
| Q3 24 | $-14.5M | $13.2M | ||
| Q2 24 | $14.5M | $6.2M |
| Q1 26 | — | — | ||
| Q4 25 | $58.2M | $-1.8M | ||
| Q3 25 | $35.4M | $-4.6M | ||
| Q2 25 | $4.5M | $-1.5M | ||
| Q1 25 | $-727.0K | $-974.0K | ||
| Q4 24 | $55.4M | $1.1M | ||
| Q3 24 | $-16.2M | $12.2M | ||
| Q2 24 | $13.2M | $5.2M |
| Q1 26 | — | — | ||
| Q4 25 | 85.5% | -2.9% | ||
| Q3 25 | 54.1% | -8.7% | ||
| Q2 25 | 7.3% | -3.2% | ||
| Q1 25 | -1.2% | -2.3% | ||
| Q4 24 | 116.4% | 1.9% | ||
| Q3 24 | -36.0% | 23.7% | ||
| Q2 24 | 30.8% | 11.0% |
| Q1 26 | — | — | ||
| Q4 25 | 8.4% | 1.6% | ||
| Q3 25 | 1.1% | 1.3% | ||
| Q2 25 | 2.4% | 3.5% | ||
| Q1 25 | 2.9% | 2.0% | ||
| Q4 24 | 11.7% | 1.6% | ||
| Q3 24 | 3.8% | 2.0% | ||
| Q2 24 | 3.0% | 2.3% |
| Q1 26 | — | — | ||
| Q4 25 | 2.83× | — | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.14× | — | ||
| Q4 24 | 4.15× | 0.21× | ||
| Q3 24 | -1.11× | 14.05× | ||
| Q2 24 | 1.21× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CAC
| Net Interest Income | $52.4M | 81% |
| Noninterest Income | $12.0M | 19% |
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
